Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

The data is pseudonymous and apparently can't be linked to actual people.

Last week Danish pharmaceutical company Novo Nordisk, the maker of the popular diabetes and weight-loss drugs Ozempic and ...

For decades, statistical analysis has remained one of clinical research's most manual processes. As AI reshapes drug ...

NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2 ...

Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its commitment to strengthening ...

Complete SAFE KIDNEY II data confirm sustained reduction in viral load and resolution of biopsy-proven BKPyV-associated nephropathy with continued antiviral effect to 38 weeks Systematic literature ...

Clinical data warehouses maximize veracity via schema-on-write and ACID guarantees, but ETL rework, limited modality support, ...

Ozempic maker Novo Nordisk faces a major cyber crisis after hackers claim a 1.3TB data breach and begin leaking sensitive ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

Managing non-EDC (Electronic Data Capture) data integration in clinical trials is a challenge that holds significant promise. As clinical studies continue to draw on data from wearable devices like ...

A new analysis found that results for less than half of the clinical studies registered in a key European database were ...